Trinh Dieu-Thuong Thi, Tran An Hoa, Nguyen Quy Thi, Bui Minh-Man Pham, Vuong Nguyen Lam
Faculty of Traditional Medicine, Faculty of Public Health, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.
University Medical Center Ho Chi Minh City, Faculty of Public Health, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.
Med Acupunct. 2024 Feb 1;36(1):12-20. doi: 10.1089/acu.2023.0062. Epub 2024 Feb 13.
Primary dysmenorrhea is a common condition that impacts quality of life significantly. Auricular therapies have shown promise for treating primary dysmenorrhea, but there is a lack of evidence specifically for auricular acupuncture (AA). This study evaluated the safety and efficacy of AA for managing primary dysmenorrhea.
A randomized, double-blinded controlled trial was conducted on 90 females with primary dysmenorrhea: an AA group; = 45) and a sham-AA (SA) group; = 45. Specific ear acupoints (i.e., Uterus, Endocrine, , Subcortex, Liver, and Kidney) were used for the intervention, which was 1 or 2 days prior to the expected menstruation onset. Outcomes were visual analogue scale (VAS) scores, ibuprofen needs, and adverse events (AEs).
The AA group had significantly lower VAS scores, compared to the SA group at menstruation onset and for up to 12 hours (mean differences [MDs] and 95% confidence intervals [CIs]: -1.08 [-1.96, -0.21] and -1.17 [-2.16, -0.18], respectively). Both groups had reductions in pain levels, compared to the prior menstrual cycle; the AA group had a significantly greater improvement. The AA group needed fewer ibuprofen tablets (MD: -0.28; 95% CI: -0.58, 0.00]). AEs were mild pain and irritation at insertion sites, all resolved spontaneously with no lasting effects.
AA is safe. It may be effective for managing primary dysmenorrhea. Further studies are warranted on AA's effectiveness in diverse populations and extended times.
原发性痛经是一种严重影响生活质量的常见病症。耳穴疗法在治疗原发性痛经方面已显示出前景,但缺乏专门针对耳针(AA)的证据。本研究评估了耳针治疗原发性痛经的安全性和有效性。
对90名原发性痛经女性进行了一项随机双盲对照试验:耳针组(n = 45)和假耳针(SA)组(n = 45)。在预期月经开始前1或2天,使用特定耳穴(即子宫、内分泌、皮质下、肝和肾)进行干预。观察指标为视觉模拟评分(VAS)、布洛芬使用需求和不良事件(AE)。
与SA组相比,耳针组在月经开始时及之后长达12小时的VAS评分显著更低(平均差值[MD]和95%置信区间[CI]:分别为-1.08[-1.96, -0.21]和-1.17[-2.16, -0.18])。与前一月经周期相比,两组疼痛程度均有所降低;耳针组改善更为显著。耳针组所需布洛芬片更少(MD:-0.28;95%CI:-0.58, 0.00])。不良事件为针刺部位轻度疼痛和刺激,均自发缓解,无持久影响。
耳针是安全的。它可能对原发性痛经有效。有必要进一步研究耳针在不同人群和更长时间内的有效性。